通过调节TGF-β/SMAD信号通路,PSME3促进了肺腺癌的发展
Shuai Wang1, Yongmeng Li2, Kai Jin1
1Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, China.
Translational lung cancer research
|July 8, 2024
概括
蛋白酶激活子单元3 (PSME3) 在肺腺癌 (LUAD) 中高度表达,促进癌症的进展. 针对PSME3可能为LUAD患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肺腺癌 (LUAD) 是全球流行的一种癌症.
- 蛋白酶激活子单元3 (PSME3) 在LUAD病原发生中的作用尚不清楚.
- 了解PSME3在LUAD中的机制对于开发有针对性的疗法至关重要.
研究的目的:
- 阐明PSME3促进LUAD进展的机制.
- 调查PSME3作为LUAD治疗的潜在分子标.
主要方法:
- 生物信息学分析,免疫组织化学,西部涂抹和qRT-PCR被用于评估PSME3表达.
- 功能性实验 (敲击/过度表达) 评估了PSME3对LUAD细胞增殖,迁移和亡的影响.
- 转录基因组测序和西方抹杀探索了潜在的分子机制,包括TGF-β/SMAD通路.
主要成果:
- 在LUAD组织中,PSME3的表达显著升高,并与患者的预后不佳有关.
- 低调PSME3抑制了LUAD细胞的增殖,入侵,迁移,并诱导了G1/S阶段细胞周期停止.
- 转变生长因子-β (TGF-β) /SMAD信号通路被确定为PSME3.3规范的关键机制.
结论:
- 在LUAD中,PSME3异常过度表达,与患者不良结果相关.
- 向PSME3为肺腺癌提供了一个有前途的新疗法策略.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
416
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
3.4K
相关概念视频
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
